data_1gfc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gfc _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.897 -1.281 . . . . 4.3799999999999999 109.897 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.44 107.96 5.06 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.603 -0.839 . . . . 3.25 110.791 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.632 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -124.35 35.9 4.72 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.492 0.663 . . . . 1.6299999999999999 110.381 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.1 m-85 -106.71 152.79 23.34 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.032 -1.067 . . . . 1.8700000000000001 112.42 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.2 m -135.46 -167.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.227 -1.351 . . . . 0.59999999999999998 108.588 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.505 ' O ' ' C ' ' A' ' 7' ' ' ALA . 3.6 mt-30 -142.34 97.41 3.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.041 . . . . 0.42999999999999999 108.188 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.38 109.76 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.256 -1.338 . . . . 0.19 112.905 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.35 -48.66 74.69 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.822 -0.626 . . . . 1.6599999999999999 109.539 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.86 -178.04 4.63 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.959 -1.126 . . . . 1.22 107.959 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.11 131.87 35.13 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.049 -1.432 . . . . 0.53000000000000003 108.455 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -116.98 106.52 13.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.883 -1.127 . . . . 0.29999999999999999 113.04 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.3 132.51 35.45 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 117.677 -1.609 . . . . 2.3799999999999999 107.729 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.63 161.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 120.24 0.627 . . . . 1.05 112.229 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 41.2 mt-30 -155.0 -5.66 0.14 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.71 -1.132 . . . . 2.7000000000000002 108.25 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -121.9 150.13 42.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.32 -1.309 . . . . 2.6000000000000001 110.117 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.31 103.23 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.943 -1.103 . . . . 3.6499999999999999 110.899 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.01 25.19 27.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.422 -1.371 . . . . 1.46 110.694 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.581 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -93.54 169.58 10.24 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.364 -0.934 . . . . 1.3500000000000001 109.02 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.581 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 2.3 tp -71.28 161.81 30.46 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.187 -0.915 . . . . 0.98999999999999999 112.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.27 121.9 1.16 Allowed Glycine 0 N--CA 1.492 2.367 0 CA-C-N 114.743 -1.117 . . . . 0.25 110.318 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.7 p90 -147.35 -170.32 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.483 -1.287 . . . . 0.20000000000000001 112.078 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.3 mmm-85 -140.99 129.84 23.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.785 -0.766 . . . . 3.7000000000000002 112.005 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.98 136.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.57 0.952 . . . . 2.6600000000000001 113.57 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.96 -17.98 42.83 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.729 -1.748 . . . . 0.34000000000000002 108.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 113.78 8.08 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.057 -1.057 . . . . 0.88 108.25 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 4.8 m-85 -72.94 108.47 5.87 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.915 -1.114 . . . . 1.1299999999999999 112.116 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.475 HG23 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -73.69 147.87 9.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.867 -1.133 . . . . 0.20000000000000001 107.999 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.8 t-160 -104.77 98.31 8.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.75 -1.204 . . . . 1.0 107.75 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.0 t -64.03 88.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.477 -1.238 . . . . 0.52000000000000002 111.577 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.445 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 16.8 ttm -73.14 -31.52 64.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.451 -1.25 . . . . 1.8100000000000001 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -171.78 97.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.25 -1.38 . . . . 1.78 111.824 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 p30 -58.42 109.47 0.79 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.894 -1.123 . . . . 2.6099999999999999 109.252 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -75.48 0.55 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.147 -1.021 . . . . 2.21 111.57 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -79.28 160.93 69.52 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 119.329 -0.948 . . . . 0.83999999999999997 111.225 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -62.77 -62.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.71 1.607 . . . . 0.5 111.185 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t-20 -88.62 4.52 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.769 -0.773 . . . . 1.1599999999999999 111.222 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 17.5 m95 -140.76 143.59 35.02 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.872 -0.788 . . . . 0.42999999999999999 108.872 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 21.1 m0 -137.7 179.95 6.12 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.748 -0.781 . . . . 0.52000000000000002 111.71 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -119.2 126.84 52.51 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.282 -1.377 . . . . 1.1200000000000001 107.282 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.25 -148.35 5.08 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 118.352 -1.88 . . . . 0.22 109.27 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.2 175.42 10.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.12 -1.432 . . . . 0.42999999999999999 112.109 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 44' ' ' GLY . 24.7 t -169.95 -87.18 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.692 -1.203 . . . . 1.02 111.631 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.592 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.3 p80 -63.74 72.59 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.751 -0.78 . . . . 1.0700000000000001 110.903 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 43.68 20.04 0.12 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.572 -1.299 . . . . 0.83999999999999997 110.873 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.1 tt0 -145.39 145.06 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.929 -1.108 . . . . 2.8199999999999998 111.362 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 p -94.97 -174.77 3.34 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.576 -0.85 . . . . 1.2 110.49 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.36 -168.16 29.05 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.166 -1.493 . . . . 0.28000000000000003 111.338 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -106.95 143.59 34.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.329 -0.548 . . . . 0.69999999999999996 110.983 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.475 ' CE2' HG23 ' A' ' 27' ' ' ILE . 5.0 p90 -146.45 144.17 20.42 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.635 -0.826 . . . . 0.22 109.421 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.79 121.42 9.94 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 120.299 0.666 . . . . 0.25 111.072 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -57.32 -25.37 59.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.624 -1.171 . . . . 3.0299999999999998 111.85 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.24 3.9 47.81 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.066 -1.054 . . . . 2.6699999999999999 112.602 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.96 10.13 42.07 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.221 -0.992 . . . . 1.02 109.229 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.437 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 10.6 m -137.3 175.96 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 114.951 -1.022 . . . . 0.20999999999999999 110.461 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -154.18 147.82 18.59 Favored Pre-proline 0 C--N 1.299 -1.607 0 C-N-CA 119.382 -0.927 . . . . 0.80000000000000004 109.214 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.89 154.07 46.71 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 120.869 1.046 . . . . 1.3400000000000001 112.089 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.7 t -94.05 -43.9 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.797 -0.761 . . . . 2.3199999999999998 110.889 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.58 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -93.52 178.38 5.72 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.396 -0.921 . . . . 5.5999999999999996 111.001 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' NE ' ' C ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.38 -1.771 . . . . 8.1699999999999999 110.555 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.897 -1.281 . . . . 3.8500000000000001 109.897 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.44 107.96 5.06 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.603 -0.839 . . . . 3.0099999999999998 110.791 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.632 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -124.35 35.9 4.72 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.492 0.663 . . . . 1.3999999999999999 110.381 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.402 ' CZ ' ' ND1' ' A' ' 28' ' ' HIS . 28.1 m-85 -106.71 152.79 23.34 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.032 -1.067 . . . . 1.3 112.42 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 15.2 m -135.46 -167.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.227 -1.351 . . . . 0.19 108.588 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.533 ' OE1' HG13 ' A' ' 57' ' ' VAL . 3.6 mt-30 -142.34 97.41 3.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.041 . . . . 0.34999999999999998 108.188 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.38 109.76 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.256 -1.338 . . . . 0.14999999999999999 112.905 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.35 -48.66 74.69 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.822 -0.626 . . . . 1.1399999999999999 109.539 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.86 -178.04 4.63 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.959 -1.126 . . . . 0.95999999999999996 107.959 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.11 131.87 35.13 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.049 -1.432 . . . . 0.53000000000000003 108.455 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -116.98 106.52 13.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.883 -1.127 . . . . 0.26000000000000001 113.04 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.3 132.51 35.45 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 117.677 -1.609 . . . . 2.3799999999999999 107.729 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.63 161.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 120.24 0.627 . . . . 1.05 112.229 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 41.2 mt-30 -155.0 -5.66 0.14 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.71 -1.132 . . . . 2.0899999999999999 108.25 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -121.9 150.13 42.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.32 -1.309 . . . . 2.6000000000000001 110.117 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.31 103.23 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.943 -1.103 . . . . 3.6499999999999999 110.899 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.01 25.19 27.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.422 -1.371 . . . . 0.93999999999999995 110.694 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -93.54 169.58 10.24 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.364 -0.934 . . . . 0.85999999999999999 109.02 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.628 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 2.3 tp -71.28 161.81 30.46 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.187 -0.915 . . . . 0.38 112.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.27 121.9 1.16 Allowed Glycine 0 N--CA 1.492 2.367 0 CA-C-N 114.743 -1.117 . . . . 0.25 110.318 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 3.7 p90 -147.35 -170.32 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.483 -1.287 . . . . 0.17000000000000001 112.078 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.3 mmm-85 -140.99 129.84 23.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.785 -0.766 . . . . 2.9700000000000002 112.005 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.98 136.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.57 0.952 . . . . 2.1899999999999999 113.57 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.96 -17.98 42.83 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.729 -1.748 . . . . 0.34000000000000002 108.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 113.78 8.08 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.057 -1.057 . . . . 0.88 108.25 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 4.8 m-85 -72.94 108.47 5.87 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.915 -1.114 . . . . 0.90000000000000002 112.116 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -73.69 147.87 9.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.867 -1.133 . . . . 0.20000000000000001 107.999 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.402 ' ND1' ' CZ ' ' A' ' 4' ' ' TYR . 15.9 t60 -104.77 98.31 8.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.75 -1.204 . . . . 0.75 107.75 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.0 t -64.03 88.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.477 -1.238 . . . . 0.33000000000000002 111.577 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.556 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 16.8 ttm -73.14 -31.52 64.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.451 -1.25 . . . . 1.47 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -171.78 97.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.25 -1.38 . . . . 1.78 111.824 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 p30 -58.42 109.47 0.79 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.894 -1.123 . . . . 1.73 109.252 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -75.48 0.55 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.147 -1.021 . . . . 1.6399999999999999 111.57 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -79.28 160.93 69.52 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 119.329 -0.948 . . . . 0.83999999999999997 111.225 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -62.77 -62.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.71 1.607 . . . . 0.42999999999999999 111.185 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -88.62 4.52 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.769 -0.773 . . . . 1.1599999999999999 111.222 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 17.5 m95 -140.76 143.59 35.02 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.872 -0.788 . . . . 0.37 108.872 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' ARG . 21.1 m0 -137.7 179.95 6.12 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.748 -0.781 . . . . 0.40000000000000002 111.71 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -119.2 126.84 52.51 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.282 -1.377 . . . . 0.83999999999999997 107.282 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.25 -148.35 5.08 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 118.352 -1.88 . . . . 0.19 109.27 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.2 175.42 10.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.12 -1.432 . . . . 0.42999999999999999 112.109 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 44' ' ' GLY . 24.7 t -169.95 -87.18 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.692 -1.203 . . . . 0.67000000000000004 111.631 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.671 ' H ' ' CD2' ' A' ' 43' ' ' HIS . 4.3 p80 -63.74 72.59 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.751 -0.78 . . . . 1.0700000000000001 110.903 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 43.68 20.04 0.12 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.572 -1.299 . . . . 0.5 110.873 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.1 tt0 -145.39 145.06 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.929 -1.108 . . . . 2.8199999999999998 111.362 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -94.97 -174.77 3.34 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.576 -0.85 . . . . 0.32000000000000001 110.49 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.36 -168.16 29.05 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.166 -1.493 . . . . 0.28000000000000003 111.338 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -106.95 143.59 34.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.329 -0.548 . . . . 0.38 110.983 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -146.45 144.17 20.42 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.635 -0.826 . . . . 0.19 109.421 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.79 121.42 9.94 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 120.299 0.666 . . . . 0.23000000000000001 111.072 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -57.32 -25.37 59.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.624 -1.171 . . . . 2.21 111.85 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.24 3.9 47.81 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.066 -1.054 . . . . 2.4700000000000002 112.602 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.96 10.13 42.07 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.221 -0.992 . . . . 0.28000000000000003 109.229 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 10.6 m -137.3 175.96 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 114.951 -1.022 . . . . 0.17999999999999999 110.461 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -154.18 147.82 18.59 Favored Pre-proline 0 C--N 1.299 -1.607 0 C-N-CA 119.382 -0.927 . . . . 0.28000000000000003 109.214 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.89 154.07 46.71 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 120.869 1.046 . . . . 1.1399999999999999 112.089 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.533 HG13 ' OE1' ' A' ' 6' ' ' GLN . 1.7 t -94.05 -43.9 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.797 -0.761 . . . . 2.3199999999999998 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.52 178.38 5.72 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.396 -0.921 . . . . 5.2699999999999996 111.001 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' NE ' ' C ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.38 -1.771 . . . . 7.4199999999999999 110.555 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.897 -1.281 . . . . 3.85 109.897 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -142.44 107.96 5.06 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.603 -0.839 . . . . 3.01 110.791 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.632 ' O ' ' OG1' ' A' ' 3' ' ' THR . 0.1 OUTLIER -124.35 35.9 4.72 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.492 0.663 . . . . 1.4 110.381 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 28' ' ' HIS . 28.1 m-85 -106.71 152.79 23.34 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.032 -1.067 . . . . 1.3 112.42 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.52 HG22 HG22 ' A' ' 27' ' ' ILE . 15.2 m -135.46 -167.99 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 114.227 -1.351 . . . . 0.19 108.588 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.533 ' OE1' HG13 ' A' ' 57' ' ' VAL . 3.6 mt-30 -142.34 97.41 3.12 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.188 -1.041 . . . . 0.35 108.188 179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' C ' ' O ' ' A' ' 6' ' ' GLN . . . -24.38 109.76 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.256 -1.338 . . . . 0.15 112.905 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.479 ' H ' ' HA ' ' A' ' 54' ' ' VAL . 0.4 OUTLIER -64.35 -48.66 74.69 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 115.822 -0.626 . . . . 1.14 109.539 -179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -130.86 -178.04 4.63 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.959 -1.126 . . . . 0.96 107.959 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.11 131.87 35.13 Favored 'General case' 0 C--N 1.266 -3.054 0 CA-C-N 114.049 -1.432 . . . . 0.53 108.455 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -116.98 106.52 13.51 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.883 -1.127 . . . . 0.26 113.04 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -90.3 132.51 35.45 Favored Pre-proline 0 C--N 1.305 -1.364 0 C-N-CA 117.677 -1.609 . . . . 2.38 107.729 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -43.63 161.04 0.06 OUTLIER 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 120.24 0.627 . . . . 1.05 112.229 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.551 ' N ' ' OE2' ' A' ' 18' ' ' GLU . 41.2 mt-30 -155.0 -5.66 0.14 Allowed 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.71 -1.132 . . . . 2.09 108.25 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -121.9 150.13 42.42 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 114.32 -1.309 . . . . 2.6 110.117 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.31 103.23 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.943 -1.103 . . . . 3.65 110.899 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 90.01 25.19 27.59 Favored Glycine 0 N--CA 1.486 1.996 0 C-N-CA 119.422 -1.371 . . . . 0.94 110.694 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.628 ' HG3' ' N ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -93.54 169.58 10.24 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.364 -0.934 . . . . 0.86 109.02 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.628 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 2.3 tp -71.28 161.81 30.46 Favored 'General case' 0 C--N 1.288 -2.088 0 CA-C-N 115.187 -0.915 . . . . 0.38 112.976 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' A' ' 43' ' ' HIS . . . -155.27 121.9 1.16 Allowed Glycine 0 N--CA 1.492 2.367 0 CA-C-N 114.743 -1.117 . . . . 0.25 110.318 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 3.7 p90 -147.35 -170.32 3.52 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.483 -1.287 . . . . 0.17 112.078 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.492 ' O ' ' C ' ' A' ' 23' ' ' ARG . 4.3 mmm-85 -140.99 129.84 23.04 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.785 -0.766 . . . . 2.97 112.005 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.492 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -14.98 136.03 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.57 0.952 . . . . 2.19 113.57 179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.96 -17.98 42.83 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.729 -1.748 . . . . 0.34 108.729 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.65 113.78 8.08 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.057 -1.057 . . . . 0.88 108.25 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 26' ' ' PHE . 4.8 m-85 -72.94 108.47 5.87 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 118.915 -1.114 . . . . 0.9 112.116 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG21 ' CE2' ' A' ' 49' ' ' PHE . 0.7 OUTLIER -73.69 147.87 9.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 C-N-CA 118.867 -1.133 . . . . 0.2 107.999 179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 4' ' ' TYR . 9.8 t-160 -104.77 98.31 8.06 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.75 -1.204 . . . . 0.75 107.75 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 ' O ' ' OG1' ' A' ' 3' ' ' THR . 10.0 t -64.03 88.95 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.477 -1.238 . . . . 0.33 111.577 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.556 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 16.8 ttm -73.14 -31.52 64.33 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.451 -1.25 . . . . 1.47 110.87 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -171.78 97.74 0.18 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 118.25 -1.38 . . . . 1.78 111.824 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.529 ' N ' ' OD1' ' A' ' 32' ' ' ASN . 4.4 p30 -58.42 109.47 0.79 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 118.894 -1.123 . . . . 1.73 109.252 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -75.48 0.55 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 119.147 -1.021 . . . . 1.64 111.57 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 37' ' ' TRP . 0.6 OUTLIER -79.28 160.93 69.52 Favored Pre-proline 0 C--N 1.296 -1.732 0 C-N-CA 119.329 -0.948 . . . . 0.84 111.225 -179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -62.77 -62.35 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.71 1.607 . . . . 0.43 111.185 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.502 ' ND2' ' O ' ' A' ' 36' ' ' ASN . 2.6 t-20 -88.62 4.52 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.769 -0.773 . . . . 1.16 111.222 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' O ' ' O ' ' A' ' 34' ' ' ASP . 17.5 m95 -140.76 143.59 35.02 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.872 -0.788 . . . . 0.37 108.872 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.401 ' CE2' ' HG3' ' A' ' 51' ' ' ARG . 21.1 m0 -137.7 179.95 6.12 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.748 -0.781 . . . . 0.4 111.71 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -119.2 126.84 52.51 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.282 -1.377 . . . . 0.84 107.282 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.556 ' HA2' ' H ' ' A' ' 30' ' ' MET . . . -157.25 -148.35 5.08 Favored Glycine 0 C--N 1.301 -1.385 0 C-N-CA 118.352 -1.88 . . . . 0.19 109.27 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' HB2' HG22 ' A' ' 46' ' ' THR . . . -164.2 175.42 10.15 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.12 -1.432 . . . . 0.43 112.109 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.476 ' O ' ' N ' ' A' ' 44' ' ' GLY . 24.7 t -169.95 -87.18 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 118.692 -1.203 . . . . 0.67 111.631 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.671 ' CD2' ' H ' ' A' ' 43' ' ' HIS . 4.3 p80 -63.74 72.59 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.751 -0.78 . . . . 1.07 110.903 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' CYS . . . 43.68 20.04 0.12 Allowed Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.572 -1.299 . . . . 0.5 110.873 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' HIS . 2.1 tt0 -145.39 145.06 31.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.929 -1.108 . . . . 2.82 111.362 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.778 HG22 ' HB2' ' A' ' 41' ' ' ALA . 5.1 p -94.97 -174.77 3.34 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.576 -0.85 . . . . 0.32 110.49 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.36 -168.16 29.05 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 119.166 -1.493 . . . . 0.28 111.338 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.3 mtp -106.95 143.59 34.82 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 120.329 -0.548 . . . . 0.38 110.983 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.556 ' CE2' HG21 ' A' ' 27' ' ' ILE . 5.0 p90 -146.45 144.17 20.42 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.635 -0.826 . . . . 0.19 109.421 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -55.79 121.42 9.94 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 120.299 0.666 . . . . 0.23 111.072 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' CD ' ' C ' ' A' ' 51' ' ' ARG . 0.0 OUTLIER -57.32 -25.37 59.22 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 114.624 -1.171 . . . . 2.21 111.85 -179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.24 3.9 47.81 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.066 -1.054 . . . . 2.47 112.602 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -98.96 10.13 42.07 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.221 -0.992 . . . . 0.28 109.229 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.479 ' HA ' ' H ' ' A' ' 8' ' ' LEU . 10.6 m -137.3 175.96 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 114.951 -1.022 . . . . 0.18 110.461 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -154.18 147.82 18.59 Favored Pre-proline 0 C--N 1.299 -1.607 0 C-N-CA 119.382 -0.927 . . . . 0.28 109.214 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.89 154.07 46.71 Favored 'Trans proline' 0 C--N 1.318 -1.033 0 C-N-CA 120.869 1.046 . . . . 1.14 112.089 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.533 HG13 ' OE1' ' A' ' 6' ' ' GLN . 1.7 t -94.05 -43.9 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.797 -0.761 . . . . 2.32 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.664 ' H ' ' ND2' ' A' ' 58' ' ' ASN . 0.2 OUTLIER -93.52 178.38 5.72 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.396 -0.921 . . . . 5.27 111.001 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.482 ' C ' ' NE ' ' A' ' 59' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.408 0 CA-C-O 116.38 -1.771 . . . . 7.42 110.555 -179.975 . . . . . . . . 2 2 . 1 stop_ save_